What is the projected market valuation of the Ultrasound Needle Guides Market by 2035?

The Ultrasound Needle Guides Market is projected to reach a valuation of 0.756 USD Billion by 2035. Read More

What was the market valuation of the Ultrasound Needle Guides Market in 2024?

In 2024, the Ultrasound Needle Guides Market was valued at 0.39 USD Billion. Read More

What is the expected CAGR for the Ultrasound Needle Guides Market during the forecast period 2025 - 2035?

The expected CAGR for the Ultrasound Needle Guides Market during the forecast period 2025 - 2035 is 6.2%. Read More

Which companies are considered key players in the Ultrasound Needle Guides Market?

Key players in the Ultrasound Needle Guides Market include GE Healthcare, Philips, Siemens Healthineers, and Hitachi Medical Systems. Read More

What are the main segments of the Ultrasound Needle Guides Market?

The main segments of the Ultrasound Needle Guides Market include Target Organ, Procedure Type, Needle Type, and Application. Read More

How did the valuation of the Lung segment change from 2024 to 2035?

The valuation of the Lung segment is expected to increase from 0.08 USD Billion in 2024 to 0.15 USD Billion by 2035. Read More

What is the projected valuation for the Biopsy procedure type by 2035?

The projected valuation for the Biopsy procedure type is expected to reach 0.3 USD Billion by 2035. Read More

How does the market for Fine Needle compare to Core Needle in terms of projected growth?

The Fine Needle segment is projected to grow from 0.15 USD Billion in 2024 to 0.3 USD Billion by 2035, indicating a robust growth trajectory compared to Core Needle. Read More

What is the expected valuation for the Thyroid segment by 2035?

The expected valuation for the Thyroid segment is projected to reach 0.1 USD Billion by 2035. Read More

Ultrasound Needle Guides Market

Q: What applications are driving growth in the Ultrasound Needle Guides Market?

Applications driving growth include Medical Diagnostics, Cancer Treatment, Pain Management, and Cosmetic Procedures. Read More

ID: MRFR/HC/26008-HCR

100 Pages

Rahul Gotadki

Last Updated: May 15, 2026

Ultrasound Needle Guides Market Research Report: Size, Share, Trend Analysis By Target Organ (Lung, Liver, Kidney, Prostate, Thyroid), By Procedure Type (Biopsy, Ablation, Aspiration, Drainage), By Needle Type (Core Needle, Fine Needle, Radiofrequency Ablation Needle), By Applications (Medical Diagnostics, Cancer Treatment, Pain Management, Cosmetic Procedures) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Target Organ (USD Billion)
  1. 4.1.1 Lung
  2. 4.1.2 Liver
  3. 4.1.3 Kidney
  4. 4.1.4 Prostate
  5. 4.1.5 Thyroid
2. 4.2 Healthcare, BY Procedure Type (USD Billion)
  1. 4.2.1 Biopsy
  2. 4.2.2 Ablation
  3. 4.2.3 Aspiration
  4. 4.2.4 Drainage
3. 4.3 Healthcare, BY Needle Type (USD Billion)
  1. 4.3.1 Core Needle
  2. 4.3.2 Fine Needle
  3. 4.3.3 Radiofrequency Ablation Needle
4. 4.4 Healthcare, BY Application (USD Billion)
  1. 4.4.1 Medical Diagnostics
  2. 4.4.2 Cancer Treatment
  3. 4.4.3 Pain Management
  4. 4.4.4 Cosmetic Procedures
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 GE Healthcare (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Philips (NL)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Siemens Healthineers (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Hitachi Medical Systems (JP)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Fujifilm (JP)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Mindray (CN)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Samsung Medison (KR)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Esaote (IT)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Canon Medical Systems (JP)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY TARGET ORGAN
4. 6.4 US MARKET ANALYSIS BY PROCEDURE TYPE
5. 6.5 US MARKET ANALYSIS BY NEEDLE TYPE
6. 6.6 US MARKET ANALYSIS BY APPLICATION
7. 6.7 CANADA MARKET ANALYSIS BY TARGET ORGAN
8. 6.8 CANADA MARKET ANALYSIS BY PROCEDURE TYPE
9. 6.9 CANADA MARKET ANALYSIS BY NEEDLE TYPE
10. 6.10 CANADA MARKET ANALYSIS BY APPLICATION
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY TARGET ORGAN
13. 6.13 GERMANY MARKET ANALYSIS BY PROCEDURE TYPE
14. 6.14 GERMANY MARKET ANALYSIS BY NEEDLE TYPE
15. 6.15 GERMANY MARKET ANALYSIS BY APPLICATION
16. 6.16 UK MARKET ANALYSIS BY TARGET ORGAN
17. 6.17 UK MARKET ANALYSIS BY PROCEDURE TYPE
18. 6.18 UK MARKET ANALYSIS BY NEEDLE TYPE
19. 6.19 UK MARKET ANALYSIS BY APPLICATION
20. 6.20 FRANCE MARKET ANALYSIS BY TARGET ORGAN
21. 6.21 FRANCE MARKET ANALYSIS BY PROCEDURE TYPE
22. 6.22 FRANCE MARKET ANALYSIS BY NEEDLE TYPE
23. 6.23 FRANCE MARKET ANALYSIS BY APPLICATION
24. 6.24 RUSSIA MARKET ANALYSIS BY TARGET ORGAN
25. 6.25 RUSSIA MARKET ANALYSIS BY PROCEDURE TYPE
26. 6.26 RUSSIA MARKET ANALYSIS BY NEEDLE TYPE
27. 6.27 RUSSIA MARKET ANALYSIS BY APPLICATION
28. 6.28 ITALY MARKET ANALYSIS BY TARGET ORGAN
29. 6.29 ITALY MARKET ANALYSIS BY PROCEDURE TYPE
30. 6.30 ITALY MARKET ANALYSIS BY NEEDLE TYPE
31. 6.31 ITALY MARKET ANALYSIS BY APPLICATION
32. 6.32 SPAIN MARKET ANALYSIS BY TARGET ORGAN
33. 6.33 SPAIN MARKET ANALYSIS BY PROCEDURE TYPE
34. 6.34 SPAIN MARKET ANALYSIS BY NEEDLE TYPE
35. 6.35 SPAIN MARKET ANALYSIS BY APPLICATION
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY TARGET ORGAN
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY PROCEDURE TYPE
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY NEEDLE TYPE
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY TARGET ORGAN
42. 6.42 CHINA MARKET ANALYSIS BY PROCEDURE TYPE
43. 6.43 CHINA MARKET ANALYSIS BY NEEDLE TYPE
44. 6.44 CHINA MARKET ANALYSIS BY APPLICATION
45. 6.45 INDIA MARKET ANALYSIS BY TARGET ORGAN
46. 6.46 INDIA MARKET ANALYSIS BY PROCEDURE TYPE
47. 6.47 INDIA MARKET ANALYSIS BY NEEDLE TYPE
48. 6.48 INDIA MARKET ANALYSIS BY APPLICATION
49. 6.49 JAPAN MARKET ANALYSIS BY TARGET ORGAN
50. 6.50 JAPAN MARKET ANALYSIS BY PROCEDURE TYPE
51. 6.51 JAPAN MARKET ANALYSIS BY NEEDLE TYPE
52. 6.52 JAPAN MARKET ANALYSIS BY APPLICATION
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY TARGET ORGAN
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY PROCEDURE TYPE
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY NEEDLE TYPE
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
57. 6.57 MALAYSIA MARKET ANALYSIS BY TARGET ORGAN
58. 6.58 MALAYSIA MARKET ANALYSIS BY PROCEDURE TYPE
59. 6.59 MALAYSIA MARKET ANALYSIS BY NEEDLE TYPE
60. 6.60 MALAYSIA MARKET ANALYSIS BY APPLICATION
61. 6.61 THAILAND MARKET ANALYSIS BY TARGET ORGAN
62. 6.62 THAILAND MARKET ANALYSIS BY PROCEDURE TYPE
63. 6.63 THAILAND MARKET ANALYSIS BY NEEDLE TYPE
64. 6.64 THAILAND MARKET ANALYSIS BY APPLICATION
65. 6.65 INDONESIA MARKET ANALYSIS BY TARGET ORGAN
66. 6.66 INDONESIA MARKET ANALYSIS BY PROCEDURE TYPE
67. 6.67 INDONESIA MARKET ANALYSIS BY NEEDLE TYPE
68. 6.68 INDONESIA MARKET ANALYSIS BY APPLICATION
69. 6.69 REST OF APAC MARKET ANALYSIS BY TARGET ORGAN
70. 6.70 REST OF APAC MARKET ANALYSIS BY PROCEDURE TYPE
71. 6.71 REST OF APAC MARKET ANALYSIS BY NEEDLE TYPE
72. 6.72 REST OF APAC MARKET ANALYSIS BY APPLICATION
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY TARGET ORGAN
75. 6.75 BRAZIL MARKET ANALYSIS BY PROCEDURE TYPE
76. 6.76 BRAZIL MARKET ANALYSIS BY NEEDLE TYPE
77. 6.77 BRAZIL MARKET ANALYSIS BY APPLICATION
78. 6.78 MEXICO MARKET ANALYSIS BY TARGET ORGAN
79. 6.79 MEXICO MARKET ANALYSIS BY PROCEDURE TYPE
80. 6.80 MEXICO MARKET ANALYSIS BY NEEDLE TYPE
81. 6.81 MEXICO MARKET ANALYSIS BY APPLICATION
82. 6.82 ARGENTINA MARKET ANALYSIS BY TARGET ORGAN
83. 6.83 ARGENTINA MARKET ANALYSIS BY PROCEDURE TYPE
84. 6.84 ARGENTINA MARKET ANALYSIS BY NEEDLE TYPE
85. 6.85 ARGENTINA MARKET ANALYSIS BY APPLICATION
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TARGET ORGAN
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE TYPE
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY NEEDLE TYPE
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TARGET ORGAN
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY PROCEDURE TYPE
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY NEEDLE TYPE
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TARGET ORGAN
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY PROCEDURE TYPE
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY NEEDLE TYPE
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
99. 6.99 REST OF MEA MARKET ANALYSIS BY TARGET ORGAN
100. 6.100 REST OF MEA MARKET ANALYSIS BY PROCEDURE TYPE
101. 6.101 REST OF MEA MARKET ANALYSIS BY NEEDLE TYPE
102. 6.102 REST OF MEA MARKET ANALYSIS BY APPLICATION
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY TARGET ORGAN, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY TARGET ORGAN, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY PROCEDURE TYPE, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY NEEDLE TYPE, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY NEEDLE TYPE, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.2.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.2.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.2.4 BY APPLICATION, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.3.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.3.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.3.4 BY APPLICATION, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.4.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.4.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.4.4 BY APPLICATION, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.5.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.5.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.5.4 BY APPLICATION, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.6.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.6.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.6.4 BY APPLICATION, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.7.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.7.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.7.4 BY APPLICATION, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.8.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.8.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.8.4 BY APPLICATION, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.9.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.9.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.9.4 BY APPLICATION, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.10.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.10.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.10.4 BY APPLICATION, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.11.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.11.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.11.4 BY APPLICATION, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.12.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.12.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.12.4 BY APPLICATION, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.13.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.13.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.13.4 BY APPLICATION, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.14.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.14.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.14.4 BY APPLICATION, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.15.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.15.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.15.4 BY APPLICATION, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.16.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.16.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.16.4 BY APPLICATION, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.17.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.17.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.17.4 BY APPLICATION, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.18.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.18.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.18.4 BY APPLICATION, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.19.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.19.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.19.4 BY APPLICATION, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.20.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.20.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.20.4 BY APPLICATION, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.21.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.21.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.21.4 BY APPLICATION, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.22.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.22.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.22.4 BY APPLICATION, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.23.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.23.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.23.4 BY APPLICATION, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.24.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.24.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.24.4 BY APPLICATION, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.25.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.25.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.25.4 BY APPLICATION, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.26.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.26.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.26.4 BY APPLICATION, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.27.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.27.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.27.4 BY APPLICATION, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.28.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.28.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.28.4 BY APPLICATION, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.29.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.29.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.29.4 BY APPLICATION, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  2. 7.30.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  3. 7.30.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  4. 7.30.4 BY APPLICATION, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Ultrasound Needle Guides Market Segmentation

Ultrasound Needle Guides Market By Target Organ (USD Billion, 2025-2035)

Lung
Liver
Kidney
Prostate
Thyroid

Ultrasound Needle Guides Market By Procedure Type (USD Billion, 2025-2035)

Biopsy
Ablation
Aspiration
Drainage

Ultrasound Needle Guides Market By Needle Type (USD Billion, 2025-2035)

Core Needle
Fine Needle
Radiofrequency Ablation Needle

Ultrasound Needle Guides Market By Application (USD Billion, 2025-2035)

Medical Diagnostics
Cancer Treatment
Pain Management
Cosmetic Procedures

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”